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Introduction
Accessibility to termination services varies around the UK.  Although the 
standard option for many years has been surgical termination (STOP) the 
number of medical terminations (MTOP) has more than doubled in the last 
5 years, accounting for 38% of all terminations in 20081.
Although MTOP and STOP are effective and acceptable below 13 weeks’ 
gestation there are no published randomised controlled trials (RCT) 
comparing efficacy and acceptability of the two methods between 13 and 
20 weeks gestation.
Future research
n Further research is needed to confirm the results of this pilot RCT and 
also to investigate the longer term repercussions for women e.g. 
acceptance, regret.
n Future studies need to consider methods to improve follow up rates. 
A PILOT RCT COMPARING 
SURGICAL AND MEDICAL TERMINATION 
13-20 WEEKS GESTATION
Methods
Design: a pilot RCT was undertaken to investigate the psychological 
impact, acceptability and effectiveness of medical vs. surgical TOP at 13-
20 weeks’ gestation.
Hypothesis: Compared to STOP, MTOP is associated with greater 
psychological distress at 2 weeks after the procedure, as measured using 
the Impact of Event Scale2 (IES)
Primary outcome: IES. In order to detect a 5 point difference in the 
IES at 5% level (90% power) and allowing for a 20% loss to follow up 
required 64 women per group.
Secondary outcomes: Efficacy; acceptability; physical symptoms; 
and psychological outcomes.
Recruitment : Over 46 months 720 women were eligible. Limited 
research nurse time allowed 229 women to be approached (after 
counselling and decision to terminate); 20 declined any part in the study. 
87 declined randomisation but gave a reason for preference.  122 women 
were randomised: 60 to MTOP using Mifepristone and Misoprostol, and 
62 to STOP using vacuum aspiration <14+6 wks gestation and D&E >15 
weeks gestation.
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Acceptability
Women preferred STOP; fewer 
women in the MTOP group would 
choose the same procedure again 
(p=.000), and more women in the 
MTOP group found the experience 
worse than expected (p=.000).
Discussion
This is the second RCT comparing MTOP and STOP after 14 weeks 
gestation. The first by Grimes et al.3 was abandoned after 12 months 
because women were unwilling to be randomised (most preferring STOP).
Follow-up response rate was only 46%: n=30 in the MTOP group and n=26 
in the STOP group. Follow up rates may have been improved with 
additional methods of data collection e.g. telephone, text and/or web based 
questionnaires.
Overall complications were similar in both groups although numbers were 
small.  There were more evacuation of retained products (ERPC) in the 
MTOP group and more haemorrhage (i.e. blood loss >500ml) in the STOP 
group.  
There were 16 unexpected overnight stays in the MTOP group which may 
have contributed to dissatisfaction with the procedure.
More women preferred STOP.  Prior studies have suggested that seeing 
the fetus, pain and prolonged bleeding contribute to dissatisfaction with 
MTOP and future preference for STOP.
Despite the acceptability and effectiveness of STOP, access to mid-
trimester surgical abortion, especially dilatation and evacuation, within the 
NHS is limited. Of 71% of NHS hospitals that provide facilities for abortion 
>13wks gestation the majority (79%) only provide MTOP4. Of the 11% of 
abortion providers from the private sector 88% offer STOP. 
Conclusions
n STOP and MTOP are equally effective at 13-20 weeks gestation.
n MTOP may be associated with more intrusive thoughts and impact 
negatively on psychological and emotional wellbeing.
n More women prefer STOP but some women would choose MTOP to 
avoid GA and surgery.
n Ideally both methods should be available to allow women their preferred 
option.
Impact of Event Scale
There was no difference between 
groups in mean  IES scores, 
however mean scores on the 
intrusion subscale were higher in 
the MTOP group (p=0.017).
Results
Symptoms
Women in the MTOP group 
experienced more bleeding (p=0.009), 
more pain on day of procedure 
(p=0.016) and more days of pain 
(p=0.032).
General Health Questionnaire
GHQ-12 scores were higher after 
MTOP (p=0.042).
Hospital Anxiety & Depression Scale
There were no differences in the 
anxiety and depression subscales 
between groups.
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Complications
Overall complication rates were 
similar between groups.
Women in the MTOP group required 
more ‘ERPC’ procedures and had 
more unexpected overnight stays. 
Women in the STOP group had 
more haemorrhage (i.e. >500ml 
blood loss).
Values mean except *Median
Values mean except *Median
References
1. DOH Abortion Statistics, England & Wales 2008. Statistical Bulletin 2009 2. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale – Measure of Subjective Stress. Psychosomatic Medicine. 
1979:41(3):209-18. 3. Grimes DA, Smith MS, Witham AD. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial. BJOG. 
2004:111(2):148-53.  4. RCOG National Audit of Induced Abortion 2000. London 2001.
